These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6332189)

  • 21. Kinetics of drug action in disease states. XVI. Pharmacodynamics of theophylline-induced seizures in rats.
    Ramzan IM; Levy G
    J Pharmacol Exp Ther; 1986 Mar; 236(3):708-13. PubMed ID: 3485196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased sensitivity to the anesthetic effect of phenobarbital in aging BN/BiRij rats.
    Stijnen AM; Danhof M; Van Bezooijen CF
    J Pharmacol Exp Ther; 1992 Apr; 261(1):81-7. PubMed ID: 1560386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic modeling of the anticonvulsant action of phenobarbital in rats.
    Dingemanse J; van Bree JB; Danhof M
    J Pharmacol Exp Ther; 1989 May; 249(2):601-8. PubMed ID: 2724142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of pregnancy on ethanol concentrations at onset of loss of righting reflex in rats.
    Hisaoka M; Levy G
    Pediatr Pharmacol (New York); 1985; 5(1):1-5. PubMed ID: 3873059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinetics of drug action in disease states. XXV. Effect of experimental hypovolemia on the pharmacodynamics and pharmacokinetics of desmethyldiazepam.
    Klockowski PM; Levy G
    J Pharmacol Exp Ther; 1988 May; 245(2):508-12. PubMed ID: 2835474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of experimental renal failure on sulfate retention and acetaminophen pharmacokinetics in rats.
    Lin JH; Levy G
    J Pharmacol Exp Ther; 1982 Apr; 221(1):80-4. PubMed ID: 7062293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetics of drug action in disease states XII: Effect of experimental liver diseases on the pharmacodynamics of phenobarbital and ethanol in rats.
    Danhof M; Hisaoka M; Levy G
    J Pharm Sci; 1985 Mar; 74(3):321-4. PubMed ID: 4009441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetics of drug action in disease states. XXXIX. Effect of orally administered activated charcoal on the hypnotic activity of phenobarbital and the neurotoxicity of theophylline administered intravenously to rats with renal failure.
    Hoffman A; Levy G
    Pharm Res; 1990 Mar; 7(3):242-6. PubMed ID: 2339096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of experimental renal failure on the disposition kinetics of l-propranolol in rats.
    Terao N; Shen DD
    J Pharmacol Exp Ther; 1983 Nov; 227(2):295-301. PubMed ID: 6631714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetics of drug action in disease states XI: effect of nicotine on the pharmacodynamics and pharmacokinetics of phenobarbital and ethanol in rats.
    Hisaoka M; Levy G
    J Pharm Sci; 1985 Apr; 74(4):412-5. PubMed ID: 3999001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacodynamics of zoxazolamine and chlorzoxazone in rats.
    Yasuhara M; Levy G
    Pharm Res; 1988 Jul; 5(7):401-7. PubMed ID: 3247308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kinetics of drug action in disease states. XXXIII: Disparate effects of pentylenetetrazol in rats as a function of renal disease model and pharmacologic endpoint.
    Ramzan I; Levy G
    J Pharm Sci; 1989 Feb; 78(2):142-5. PubMed ID: 2715936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of acute renal failure induced by uranyl nitrate on the pharmacokinetics of intravenous theophylline in rats: the role of CYP2E1 induction in 1,3-dimethyluric acid formation.
    Yu SY; Chung HC; Kim EJ; Kim SH; Lee I; Kim SG; Lee MG
    J Pharm Pharmacol; 2002 Dec; 54(12):1687-92. PubMed ID: 12542900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered dose-to-effect of propofol due to pharmacokinetics in rats with experimental diabetes mellitus.
    Leal N; Calvo R; Agrad FZ; Lukas JC; de la Fuente L; Suarez E
    J Pharm Pharmacol; 2005 Mar; 57(3):317-25. PubMed ID: 15807987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic changes of methotrexate after intravenous administration to uranyl nitrate-induced acute renal failure rats.
    Park JM; Moon CH; Lee MG
    Res Commun Mol Pathol Pharmacol; 1996 Sep; 93(3):353-62. PubMed ID: 8896046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endogenous gamma-aminobutyric acid (GABA)(A) receptor active neurosteroids and the sedative/hypnotic action of gamma-hydroxybutyric acid (GHB): a study in GHB-S (sensitive) and GHB-R (resistant) rat lines.
    Barbaccia ML; Carai MA; Colombo G; Lobina C; Purdy RH; Gessa GL
    Neuropharmacology; 2005 Jul; 49(1):48-58. PubMed ID: 15992580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinetics of drug action in disease states. XXXII: Effect of experimental hypertension on the pharmacodynamics of phenobarbital in rats.
    Walker JS; Levy G
    J Pharm Sci; 1989 Sep; 78(9):742-4. PubMed ID: 2585267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic fate of phenobarbital. A quantitative study of p-hydroxyphenobarbital elimination in man.
    Whyte MP; Dekaban AS
    Drug Metab Dispos; 1977; 5(1):63-70. PubMed ID: 13977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic developmental lead exposure and hippocampal long-term potentiation: biphasic dose-response relationship.
    Gilbert ME; Mack CM; Lasley SM
    Neurotoxicology; 1999 Feb; 20(1):71-82. PubMed ID: 10091860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction of constitutive and phenobarbital-induced cytochrome P-450 isozymes during the sequential oxidation of benzphetamine. Explanation for the difference in benzphetamine-induced hydrogen peroxide production and 455-nm complex formation in microsomes from untreated and phenobarbital-treated rats.
    Jeffery EH; Mannering GJ
    Mol Pharmacol; 1983 May; 23(3):748-57. PubMed ID: 6865917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.